Cancer stem cells synthesize proline to attenuate oxidative stress

Area of Science:

• Oncology
• Cancer Metabolism
• Molecular Biology

Background:

• Cancer cells alter metabolism for growth and survival.
• Amino acid metabolism is crucial for tumor progression.
• Cancer stem cells (CSCs) drive tumor growth and recurrence.

Purpose of the Study:

• Investigate amino acid metabolism in glioblastoma CSCs.
• Identify mechanisms maintaining CSC state.
• Explore therapeutic targets related to CSC metabolism.

Main Methods:

• Assessed amino acid levels in glioblastoma CSCs vs. differentiated cells.
• Studied the role of signaling molecule FAM3C and transcription factor SOX2.
• Investigated FAM3C interaction with histone reader SPIN1.
• Utilized genetic targeting and molecular docking (tucatinib).

Main Results:

• CSCs showed elevated proline levels due to increased synthesis.
• SOX2-induced FAM3C drives proline synthesis enzymes.
• Intracellular FAM3C binds SPIN1, promoting proline synthesis and ROS depletion.
• Targeting FAM3C reduced ROS scavenging; SPIN1 overexpression restored it.
• Tucatinib disrupts FAM3C-SPIN1 interaction, reducing proline and promoting SPIN1 degradation.

Conclusions:

• Glioblastoma CSCs create a pro-survival metabolic state via proline synthesis and ROS depletion.
• The FAM3C-SPIN1-proline axis represents a potential therapeutic vulnerability.
• Tucatinib shows promise in disrupting this CSC-sustaining pathway.